A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy

Shoichi Iriguchi(Kaneka (United States)), Shin Kaneko(Kyoto University Hospital)
Nature Communications
January 18, 2021
Cited by 209


Related Papers